Gagan Kaushal, Ph.D.
Scientific Advisor, R&D
Dr. Gagan Kaushal is a Professor of Pharmaceutical Sciences at Thomas Jefferson University and a recognized expert in formulation science, drug delivery, and regulatory-aligned development. He holds a PhD in Industrial Pharmacy from St. John’s University and brings over two decades of translational research and industry collaboration to ONNIX.
His work covers formulation and process development, advanced drug delivery systems, pharmacokinetics, as well as drug stability and solubility enhancement. Kaushal has published over 50 peer-reviewed papers in both the journal of pharmaceutical sciences and journal of applied drug development, and has led NIH and Gates Foundation funded programs in collaboration with institutions like Northwestern University, Indiana University, and the Lurie Children’s Hospital of Chicago.
As our formulation advisor, Dr. Kaushal brings a cGMP and CMC grounded perspective to keep our manufacturing decisions scalable and regulator-ready as we progress toward clinical studies.
Jared
Navarre
Chief Executive Officer
Jared Navarre is a high-IQ strategist and operational architect who has founded, scaled, and led numerous successful companies across healthcare, infrastructure, real estate, logistics, and creative sectors. With a verified IQ of 156 on the WAIS-IV, he is widely regarded as one of the most effective leaders and problem-solvers in business — known for bringing order to complexity and translating fragmented systems into aligned strategy, execution, and growth. Navarre is often brought in to lead high-stakes transitions and unlock stalled momentum at the leadership and board level.
He is the founder and CEO of Keyni, a consultancy that has advised over 250 companies — including Fortune 50 firms and mid-market operators — across technology, healthcare, infrastructure, and finance. His clients include Microsoft, Steris, Capital One, Reebok, Adobe, HCA Healthcare, and the City of Atlanta.
Navarre currently owns and operates ventures in real estate, logistics, and field services, including JPACK, Rock Solid Plumbing & Heating, VONA, and Potluck Lunch Records, and has held C-suite roles in over 15 companies. He sold his first IT firm at age 17 and has since built a reputation as a trusted advisor to boards and executive teams navigating high-stakes transitions.
Dr. Gagan Kaushal is a Professor of Pharmaceutical Sciences at Thomas Jefferson University and a recognized expert in formulation science, drug delivery, and regulatory-aligned development. He holds a PhD in Industrial Pharmacy from St. John’s University and brings over two decades of translational research and industry collaboration to ONNIX.
His work covers formulation and process development, advanced drug delivery systems, pharmacokinetics, as well as drug stability and solubility enhancement. Kaushal has published over 50 peer-reviewed papers in both the journal of pharmaceutical sciences and journal of applied drug development, and has led NIH and Gates Foundation funded programs in collaboration with institutions like Northwestern University, Indiana University, and the Lurie Children’s Hospital of Chicago.
As our formulation advisor, Dr. Kaushal brings a cGMP and CMC grounded perspective to keep our manufacturing decisions scalable and regulator-ready as we progress toward clinical studies.
